Evidence map›Paper›PMID 37177375›Full record

ArticlePolymers2023

Preparation of Polylactic Acid/Calcium Peroxide Composite Filaments for Fused Deposition Modelling.

Abdullah H Mohammed, Nikolina Kovacev, Amr Elshaer, Ammar A Melaibari, Javed Iqbal, Hany Hassanin, Khamis Essa, Adnan Memić

Abstract read
In one paragraph

Article in Polymers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Abdullah H MohammedSchool of Engineering, University of Birmingham, Birmingham B15 2TT, UK.ORCID 0000-0002-5264-8824
Nikolina KovacevSchool of Engineering, University of Birmingham, Birmingham B15 2TT, UK.ORCID 0000-0001-8392-7394
Amr ElshaerDrug Discovery, Delivery and Patient Care (DDDPC), School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Kingston upon Thames KT1 2EE, UK.ORCID 0000-0002-5058-0256
Ammar A MelaibariCenter of Nanotechnology, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0002-0967-6774
Javed IqbalCenter of Nanotechnology, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0003-0957-3641
Hany HassaninSchool of Engineering, Canterbury Christ Church University, Canterbury CT1 1QU, UK.ORCID 0000-0002-8646-0520
Khamis EssaSchool of Engineering, University of Birmingham, Birmingham B15 2TT, UK.ORCID 0000-0001-6090-0869
Adnan MemićCenter of Nanotechnology, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0003-4639-8168

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fused Deposition Modelling (FDM) 3D printers have gained significant popularity in the pharmaceutical and biomedical industries. In this study, a new biomaterial filament was developed by preparing a polylactic acid (PLA)/calcium peroxide (CPO) composite using wet solution mixing and extrusion. The content of CPO varied from 3% to 24% wt., and hot-melt extruder parameters were optimised to fabricate 3D printable composite filaments. The filaments were characterised using an X-ray diffraction analysis, surface morphology assessment, evaluation of filament extrudability, microstructural analysis, and examination of their rheological and mechanical properties. Our findings indicate that increasing the CPO content resulted in increased viscosity at 200 °C, while the PLA/CPO samples showed microstructural changes from crystalline to amorphous. The mechanical strength and ductility of the composite filaments decreased except for in the 6% CPO filament. Due to its acceptable surface morphology and strength, the PLA/CPO filament with 6% CPO was selected for printability testing. The 3D-printed sample of a bone scaffold exhibited good printing quality, demonstrating the potential of the PLA/CPO filament as an improved biocompatible filament for FDM 3D printing.

Indexed as

3D printingbiomedical filamentcalcium peroxidecomposite filamentsFDM filamentspolylactic acid

Identifiers

PMID37177375
PMCPMC10181036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.